Average Co-Inventor Count = 5.70
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genelabs Technologies, Inc. (6 from 72 patents)
2. The United States of America As Represented by the Department of Health (3 from 1,215 patents)
3. Other (2 from 832,718 patents)
4. The United States of America, As Represented by the Secretary, Department of Health and Human Services (1 from 3,439 patents)
5. The United States of America (1 from 254 patents)
6. Genelabs, Incorporated (1 from 17 patents)
11 patents:
1. 7094406 - Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof
2. 6455492 - Hepatitis E virus vaccine and method
3. 6379891 - Method of detecting HEV infection
4. 6229005 - DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent
5. 6120988 - Method of detecting hev infection
6. 5885768 - Hepatitis E virus peptide antigen and antibodies
7. 5824649 - DNA sequences of enterically transmitted non-A/non-B hepatitis viral
8. 5789559 - DNA sequences of enterically transmitted non-A/non-B hepatitis viral
9. 5770689 - Hepatitis E virus ORF Z peptides
10. 5741490 - Hepatitis E virus vaccine and method
11. 5218099 - Post-transfusion, non-A, non-B hepatitis virus polynucleotides